Arax Advisory Partners’s BioNTech BNTX Stock Holding History

Arax Advisory Partners’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$111K	Buy	1,194 +1,166	+4,164%	+$110K	﹤0.01%	2651
2026 Q1	$2.49K	Buy	28 +23	+460%	+$2.36K	﹤0.01%	3043
2025 Q4	$476	Buy	+5	New	+$504	﹤0.01%	3619
2025 Q3	–	Sell	-10	Closed	-$1.06K	–	3675
2025 Q2	$1.06K	Buy	+10	New	+$1.01K	﹤0.01%	2753

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Arax Advisory Partners's BNTX Position: Q2 2026 in Review

Arax Advisory Partners increased its BioNTech (BNTX) stake by 4,164% in Q2 2026, buying an estimated $110K and bringing the position to 1,194 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #2651.

Arax Advisory Partners first reported a position in BNTX in Q2 2025 and has held it in 4 quarters since. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Arax Advisory Partners held 1,194 shares of BioNTech worth $111K as of Q2 2026.
Arax Advisory Partners bought 1,166 BioNTech shares in Q2 2026, an estimated $110K.
BioNTech made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2651 holding.
Arax Advisory Partners first reported a position in BioNTech in Q2 2025 and has held it in 4 quarters since.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.